With more than 10,000 patients diagnosed using Ibex’s Galen platform, CorePlus is leading the way for AI adoption in pathology.
Watch this interview with CorePlus CEO Mariano de Socarraz and CMO Juan Carlos Santa-Rosario MD to learn why they have chosen to use AI in primary diagnosis, the benefits it brings, and the impact using AI has had on patient care.
